HPGC Renmintongtai Pharmaceutical Corporation announced earnings results for the nine months ended September 30, 2021. For the nine months, the company announced sales was CNY 7,235.787 million compared to CNY 5,700.749 million a year ago. Operating income was CNY 305.976 million compared to CNY 191.071 million a year ago. Net income was CNY 234.405 million compared to CNY 140.735 million a year ago. Basic earnings per share from continuing operations was CNY 0.4042 compared to CNY 0.2427 a year ago.